MIT AI Drug Discovery: BoltzGen zmienia odkrywanie leków na zawsze
MIT’s BoltzGen generative AI designs proteins for cancer and rare diseases. Pichia-CLM cuts manufacturing costs. The future of medicine is here — March 2026.
MIT’s BoltzGen generative AI designs proteins for cancer and rare diseases. Pichia-CLM cuts manufacturing costs. The future of medicine is here — March 2026.